Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19-Reference-Cited by-同舟云学术

Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19

Published:2021-05-24 Issue:12 Volume:21 Page:1551-1560
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Gupta Ashim¹²³⁴^ORCID,Shivaji Kashte⁵^ORCID,Kadam Sachin⁵⁶,Gupta Manu¹,Rodriguez Hugo C.¹³⁷⁸,Potty Anish G.³⁸⁹,El-Amin Saadiq F.²¹⁰,Maffulli Nicola¹¹¹²¹³^ORCID

Affiliation:

1. Future Biologics, Lawrenceville, USA

2. BioIntegrate, Lawrenceville, USA

3. South Texas Orthopedic Research Institute (STORI Inc), Laredo, USA

4. Veterans in Pain, Los Angeles, USA

5. Department of Stem Cell & Regenerative Medicine, Centre for Interdisciplinary Research, D. Y. Patil Education Society (Institution Deemed to Be University), Kolhapur, India

6. Advancells Group, Noida, India

7. Future Physicians of South Texas, San Antonio, USA

8. School of Osteopathic Medicine, University of the Incarnate Word, San Antonio, USA

9. The Institute of Musculoskeletal Excellence (TIME Orthopaedics), Laredo, USA

10. El-Amin Orthopaedic & Sports Medicine Institute, Lawrenceville, USA

11. Department of Musculoskeletal Disorders, School of Medicine and Surgery, University of Salerno, Fisciano, Italy

12. San Giovanni Di Dio E Ruggi D’Aragona Hospital “Clinica Orthopedica” Department, Hospital of Salerno, Salerno, Italy

13. Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, London, England

Funder

received

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1921141

Reference92 articles.

1. International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19

2. COVID-19 dashboard by the center for systems science and Engineering (CSSE) at Johns Hopkins University (JHU). [cited 2020 Nov 20]. Available from: https://coronavirus.jhu.edu/map.html

3. WHO Coronavirus Disease (COVID-19) Dashboard, WHO/World Heal. Organ. (2020). [cited 2020 Nov 20]. Available from: https://covid19.who.int

4. Italy and COVID-19: the changing patient flow in an orthopedic trauma center emergency department

5. COVID-19: not a contraindication for surgery in patients with proximal femur fragility fractures

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of lyophilized exosomes derived from umbilical cord stem cells on chronic anterior cruciate ligament cell injury;Journal of Orthopaedic Surgery and Research;2024-09-09

2. From stem cells to extracellular vesicles: a new horizon in tissue engineering and regenerative medicine;Cytotechnology;2024-05-08

3. Exosomes derived from M2 macrophages prevent steroid-induced osteonecrosis of the femoral head by modulating inflammation, promoting bone formation and inhibiting bone resorption;Journal of Orthopaedic Surgery and Research;2024-04-16

4. Circ_0006640 transferred by bone marrow-mesenchymal stem cell-exosomes suppresses lipopolysaccharide-induced apoptotic, inflammatory and oxidative injury in spinal cord injury;Journal of Orthopaedic Surgery and Research;2024-01-09

5. Exosomes from bone marrow mesenchymal stem cells ameliorate glucocorticoid-induced osteonecrosis of femoral head by transferring microRNA-210 into bone microvascular endothelial cells;Journal of Orthopaedic Surgery and Research;2023-12-07